INSPIRE MEDICAL SYSTEMS INC (INSP) Stock Fundamental Analysis
USA • New York Stock Exchange • NYSE:INSP • US4577301090
68.21 USD
+0.07 (+0.1%)
At close: Feb 11, 2026
63 USD
-5.21 (-7.64%)
After Hours: 2/11/2026, 4:50:01 PM
Taking everything into account, INSP scores 6 out of 10 in our fundamental rating. INSP was compared to 186 industry peers in the Health Care Equipment & Supplies industry. INSP is in great health and has no worries on liquidiy or solvency at all, but the profibility rating is only average. INSP has a decent growth rate and is not valued too expensively.
1. Profitability
1.1 Basic Checks
- In the past year INSP was profitable.
- INSP had a positive operating cash flow in the past year.
- INSP had negative earnings in 4 of the past 5 years.
- In multiple years INSP reported negative operating cash flow during the last 5 years.
1.2 Ratios
- INSP has a better Return On Assets (5.52%) than 82.80% of its industry peers.
- With an excellent Return On Equity value of 6.69%, INSP belongs to the best of the industry, outperforming 81.72% of the companies in the same industry.
- INSP has a better Return On Invested Capital (4.82%) than 75.81% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 5.52% | ||
| ROE | 6.69% | ||
| ROIC | 4.82% |
ROA(3y)-1.48%
ROA(5y)-7.81%
ROE(3y)-1.66%
ROE(5y)-9.65%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
- INSP has a better Profit Margin (5.05%) than 77.96% of its industry peers.
- With a decent Operating Margin value of 4.16%, INSP is doing good in the industry, outperforming 68.82% of the companies in the same industry.
- INSP has a better Gross Margin (84.92%) than 94.62% of its industry peers.
- In the last couple of years the Gross Margin of INSP has remained more or less at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 4.16% | ||
| PM (TTM) | 5.05% | ||
| GM | 84.92% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.41%
GM growth 5Y0.33%
2. Health
2.1 Basic Checks
- INSP has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
- INSP has more shares outstanding than it did 1 year ago.
- The number of shares outstanding for INSP has been increased compared to 5 years ago.
- INSP has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
2.2 Solvency
- INSP has an Altman-Z score of 9.87. This indicates that INSP is financially healthy and has little risk of bankruptcy at the moment.
- INSP has a better Altman-Z score (9.87) than 88.71% of its industry peers.
- INSP has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | 0 | ||
| Altman-Z | 9.87 |
ROIC/WACC0.49
WACC9.82%
2.3 Liquidity
- A Current Ratio of 5.29 indicates that INSP has no problem at all paying its short term obligations.
- INSP's Current ratio of 5.29 is amongst the best of the industry. INSP outperforms 80.65% of its industry peers.
- A Quick Ratio of 4.01 indicates that INSP has no problem at all paying its short term obligations.
- INSP has a better Quick ratio (4.01) than 75.81% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 5.29 | ||
| Quick Ratio | 4.01 |
3. Growth
3.1 Past
- The Earnings Per Share has grown by an impressive 90.65% over the past year.
- INSP shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 16.81%.
- Measured over the past years, INSP shows a very strong growth in Revenue. The Revenue has been growing by 57.78% on average per year.
EPS 1Y (TTM)90.65%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-43.33%
Revenue 1Y (TTM)16.81%
Revenue growth 3Y50.95%
Revenue growth 5Y57.78%
Sales Q2Q%10.49%
3.2 Future
- INSP is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 18.80% yearly.
- The Revenue is expected to grow by 11.14% on average over the next years. This is quite good.
EPS Next Y-14.92%
EPS Next 2Y0.95%
EPS Next 3Y14.05%
EPS Next 5Y18.8%
Revenue Next Year13.53%
Revenue Next 2Y12.1%
Revenue Next 3Y11.94%
Revenue Next 5Y11.14%
3.3 Evolution
- Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
4. Valuation
4.1 Price/Earnings Ratio
- Based on the Price/Earnings ratio of 33.44, the valuation of INSP can be described as expensive.
- Compared to the rest of the industry, the Price/Earnings ratio of INSP indicates a somewhat cheap valuation: INSP is cheaper than 73.12% of the companies listed in the same industry.
- INSP is valuated at similar levels of the S&P average when we compare the Price/Earnings ratio to 28.03, which is the current average of the S&P500 Index.
- INSP is valuated quite expensively with a Price/Forward Earnings ratio of 38.69.
- 70.43% of the companies in the same industry are more expensive than INSP, based on the Price/Forward Earnings ratio.
- Compared to an average S&P500 Price/Forward Earnings ratio of 27.97, INSP is valued a bit more expensive.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 33.44 | ||
| Fwd PE | 38.69 |
4.2 Price Multiples
- Based on the Enterprise Value to EBITDA ratio, INSP is valued a bit cheaper than 71.51% of the companies in the same industry.
- 90.32% of the companies in the same industry are more expensive than INSP, based on the Price/Free Cash Flow ratio.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 20.06 | ||
| EV/EBITDA | 29.34 |
4.3 Compensation for Growth
- INSP's earnings are expected to grow with 14.05% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y0.95%
EPS Next 3Y14.05%
5. Dividend
5.1 Amount
- No dividends for INSP!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
68.21
+0.07 (+0.1%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)01-12 2026-01-12/amc
Earnings (Next)02-11 2026-02-11/amc
Inst Owners111.59%
Inst Owner Change-0.27%
Ins Owners0.74%
Ins Owner Change0.1%
Market Cap1.98B
Revenue(TTM)882.62M
Net Income(TTM)44.56M
Analysts80
Price Target131.09 (92.19%)
Short Float %10.28%
Short Ratio1.75
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)193.12%
Min EPS beat(2)114.53%
Max EPS beat(2)271.71%
EPS beat(4)4
Avg EPS beat(4)144.95%
Min EPS beat(4)54.07%
Max EPS beat(4)271.71%
EPS beat(8)8
Avg EPS beat(8)284.67%
EPS beat(12)12
Avg EPS beat(12)208.03%
EPS beat(16)16
Avg EPS beat(16)165.01%
Revenue beat(2)0
Avg Revenue beat(2)-0.43%
Min Revenue beat(2)-0.69%
Max Revenue beat(2)-0.17%
Revenue beat(4)1
Avg Revenue beat(4)-0.14%
Min Revenue beat(4)-0.84%
Max Revenue beat(4)1.13%
Revenue beat(8)4
Avg Revenue beat(8)0.25%
Revenue beat(12)7
Avg Revenue beat(12)1.47%
Revenue beat(16)11
Avg Revenue beat(16)3.25%
PT rev (1m)-9.17%
PT rev (3m)3.12%
EPS NQ rev (1m)31.97%
EPS NQ rev (3m)30.73%
EPS NY rev (1m)39.14%
EPS NY rev (3m)185.48%
Revenue NQ rev (1m)0.98%
Revenue NQ rev (3m)0.85%
Revenue NY rev (1m)0.29%
Revenue NY rev (3m)0.44%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 33.44 | ||
| Fwd PE | 38.69 | ||
| P/S | 2.25 | ||
| P/FCF | 20.06 | ||
| P/OCF | 14.83 | ||
| P/B | 2.97 | ||
| P/tB | 2.97 | ||
| EV/EBITDA | 29.34 |
EPS(TTM)2.04
EY2.99%
EPS(NY)1.76
Fwd EY2.58%
FCF(TTM)3.4
FCFY4.99%
OCF(TTM)4.6
OCFY6.74%
SpS30.37
BVpS22.93
TBVpS22.93
PEG (NY)N/A
PEG (5Y)N/A
Graham Number32.44
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 5.52% | ||
| ROE | 6.69% | ||
| ROCE | 5.27% | ||
| ROIC | 4.82% | ||
| ROICexc | 8.98% | ||
| ROICexgc | 8.98% | ||
| OM | 4.16% | ||
| PM (TTM) | 5.05% | ||
| GM | 84.92% | ||
| FCFM | 11.2% |
ROA(3y)-1.48%
ROA(5y)-7.81%
ROE(3y)-1.66%
ROE(5y)-9.65%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.41%
GM growth 5Y0.33%
F-Score8
Asset Turnover1.09
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | 0 | ||
| Debt/EBITDA | 0 | ||
| Cap/Depr | 276.46% | ||
| Cap/Sales | 3.95% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 270.95% | ||
| Profit Quality | 221.78% | ||
| Current Ratio | 5.29 | ||
| Quick Ratio | 4.01 | ||
| Altman-Z | 9.87 |
F-Score8
WACC9.82%
ROIC/WACC0.49
Cap/Depr(3y)638.93%
Cap/Depr(5y)518.49%
Cap/Sales(3y)3.63%
Cap/Sales(5y)3%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)90.65%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-43.33%
EPS Next Y-14.92%
EPS Next 2Y0.95%
EPS Next 3Y14.05%
EPS Next 5Y18.8%
Revenue 1Y (TTM)16.81%
Revenue growth 3Y50.95%
Revenue growth 5Y57.78%
Sales Q2Q%10.49%
Revenue Next Year13.53%
Revenue Next 2Y12.1%
Revenue Next 3Y11.94%
Revenue Next 5Y11.14%
EBIT growth 1Y172.13%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year658.15%
EBIT Next 3Y123.39%
EBIT Next 5Y70.56%
FCF growth 1Y1118.47%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y401.46%
OCF growth 3YN/A
OCF growth 5YN/A
INSPIRE MEDICAL SYSTEMS INC / INSP FAQ
What is the ChartMill fundamental rating of INSPIRE MEDICAL SYSTEMS INC (INSP) stock?
ChartMill assigns a fundamental rating of 6 / 10 to INSP.
Can you provide the valuation status for INSPIRE MEDICAL SYSTEMS INC?
ChartMill assigns a valuation rating of 4 / 10 to INSPIRE MEDICAL SYSTEMS INC (INSP). This can be considered as Fairly Valued.
How profitable is INSPIRE MEDICAL SYSTEMS INC (INSP) stock?
INSPIRE MEDICAL SYSTEMS INC (INSP) has a profitability rating of 5 / 10.
What are the PE and PB ratios of INSPIRE MEDICAL SYSTEMS INC (INSP) stock?
The Price/Earnings (PE) ratio for INSPIRE MEDICAL SYSTEMS INC (INSP) is 33.44 and the Price/Book (PB) ratio is 2.97.
What is the financial health of INSPIRE MEDICAL SYSTEMS INC (INSP) stock?
The financial health rating of INSPIRE MEDICAL SYSTEMS INC (INSP) is 8 / 10.